Meta-analysis finds RSV outcomes peak in early infancy in low- and middle-income countries
A New Map Reveals When RSV Hits Young Children Hardest
A systematic review and meta-analysis of 160 datasets from low- and middle-income countries found the peak age for severe RSV outcomes in ch…
A massive new analysis pinpoints the exact infant ages when RSV is most dangerous, providing a crucial blueprint for saving young lives.
Human metapneumovirus and respiratory syncytial virus co-circulation described in US
Two common respiratory viruses are circulating together in the US
A non-peer-reviewed report described co-circulation of human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) in the United Stat…
Two common respiratory viruses are circulating together in the US, creating a pattern that could lead to more people getting sick this seaso…
Report examines vaccination coverage for influenza, RSV, and COVID-19 in US nursing home residents
Report examines vaccination rates for flu, RSV, and COVID-19 in U.S. nursing homes
A report describes vaccination coverage for influenza, respiratory syncytial virus, and COVID-19 among nursing home residents in the United …
A new report tracks flu, RSV, and COVID-19 vaccine coverage in U.S. nursing homes to see how many residents are getting these important prot…
Field report describes nirsevimab rollout for RSV prevention in New York City infants
How many New York City infants got the new RSV shot this season?
A field report describes the rollout of nirsevimab for RSV prevention in infants born during the recommended administration period in New Yo…
New York City health officials released an early look at how many eligible infants received the new RSV shot this season.
Palivizumab reduces medically attended RSV infections in preterm infants, shows similar efficacy to nirsevimab
Can an older RSV drug protect healthy preterm babies from doctor visits?
A meta-analysis of three randomized, placebo-controlled studies in 2,464 healthy infants born ≤35 weeks' gestational age found palivizumab r…
An older RSV shot cuts doctor visits for preterm babies by 70%, matching newer drugs, though safety details remain unclear.